Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth J Morgan

Showing results (21-30 of 511) with videos related to

Pageof 52
Sort By:
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|August 12, 2011
Targeting bone as a therapy for myelomaPing Wu, Gareth J Morgan
Journal of Molecular Biology|August 30, 2016
The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable DomainsGareth J Morgan, Jeffery W Kelly
Oncotarget|November 8, 2017
Hyperhaploid karyotypes in multiple myelomaJeffrey R Sawyer, Gareth J Morgan
Hematology/Oncology Clinics of North America|October 25, 2020
The Process of Amyloid Formation due to Monoclonal ImmunoglobulinsGareth J Morgan, Jonathan S Wall
European Heart Journal. Cardiovascular Imaging|June 13, 2020
Use of Occlutech® atrial flow regulator in a single ventricle patient: a 3D view of a successful interventionJenny E Zablah, Gareth J Morgan
Blood|December 11, 2025
Improving MM outcomes with bispecific antibody combinationsFaith E Davies, Gareth J Morgan
Blood|December 18, 2025
Molecular modeling of Waldenström macroglobulinemiaGareth J Morgan, Faith E Davies
Hematology. American Society of Hematology. Education Program|December 13, 2012
What is the evidence for the use of bisphosphonate therapy in newly diagnosed multiple myeloma patients lacking bone disease?Frederick L Locke, Gareth J Morgan
Critical Reviews in Oncology/Hematology|July 6, 2013
Role of thalidomide in the treatment of patients with multiple myelomaGareth J Morgan, Faith E Davies
Interventional Cardiology Clinics|November 20, 2018
Pulmonary Artery StentingJenny E Zablah, Gareth J Morgan
Pageof 52

Showing results (21-30 of 511) with videos related to

Sort By:
Pageof 52
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|August 12, 2011
Targeting bone as a therapy for myelomaPing Wu, Gareth J Morgan
Journal of Molecular Biology|August 30, 2016
The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable DomainsGareth J Morgan, Jeffery W Kelly
Oncotarget|November 8, 2017
Hyperhaploid karyotypes in multiple myelomaJeffrey R Sawyer, Gareth J Morgan
Hematology/Oncology Clinics of North America|October 25, 2020
The Process of Amyloid Formation due to Monoclonal ImmunoglobulinsGareth J Morgan, Jonathan S Wall
European Heart Journal. Cardiovascular Imaging|June 13, 2020
Use of Occlutech® atrial flow regulator in a single ventricle patient: a 3D view of a successful interventionJenny E Zablah, Gareth J Morgan
Blood|December 11, 2025
Improving MM outcomes with bispecific antibody combinationsFaith E Davies, Gareth J Morgan
Blood|December 18, 2025
Molecular modeling of Waldenström macroglobulinemiaGareth J Morgan, Faith E Davies
Hematology. American Society of Hematology. Education Program|December 13, 2012
What is the evidence for the use of bisphosphonate therapy in newly diagnosed multiple myeloma patients lacking bone disease?Frederick L Locke, Gareth J Morgan
Critical Reviews in Oncology/Hematology|July 6, 2013
Role of thalidomide in the treatment of patients with multiple myelomaGareth J Morgan, Faith E Davies
Interventional Cardiology Clinics|November 20, 2018
Pulmonary Artery StentingJenny E Zablah, Gareth J Morgan
Pageof 52